1 | 100 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine (Synonym: Brimonidine Tartrate Ophthalmic Solution) | [1] D07540
D07540
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |
2 | 200 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine (Synonym: Brimonidine Tartrate Ophthalmic Solution) | [1] D07540
D07540
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |
3 | 400 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine (Synonym: Brimonidine Tartrate Ophthalmic Solution) | [1] D07540
D07540
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |
4 | Brimonidine tartrate | [1] Brimonidine Brimonidine (Synonym: Brimonidine Tartrate Ophthalmic Solution) | [1] D07540
D07540
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2] 13 13, 90 |
5 | Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System | [1] Brimonidine Brimonidine (Synonym: Brimonidine Tartrate Ophthalmic Solution) | [1] D07540
D07540
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |